Abstract:Background: Over the past two decades, there has been significant advancement in the management of cervical cancer, particularly in the domain of definitive chemoradiotherapy for locally advanced cervical cancer (LACC). Indeed, radiation treatment paradigms have shifted from a two-dimensional (2D) approach solely based on anatomical bony landmarks, to an image-guided three-dimensional (3D) approach, with the goal of delivering doses more precisely to clinical targets with an increased sparing of organs-at-risk. Methods: This is a narrative review on the advances in radiation technologies for the treatment of cervical cancer. Using the PubMed database, we identified articles published in English up until November 18, 2021 on the treatment of LACC with external beam radiotherapy (EBRT) and brachytherapy. A search of the Clinicaltrials.gov and Clinicaltrialsregister.eu retrieved information on ongoing clinical trials on the topic of combined immunotherapy and radiotherapy in cervical cancer. Results: We highlight the historical evolution from the use of 2D radiotherapy to 3D-conformal radiotherapy, and then intensity modulated radiotherapy (IMRT) for the delivery of EBRT. We also discuss advances in brachytherapy, notably the transition to 3D image-guided adaptive brachytherapy (3D-IGABT). In this context, we highlight large cohort studies that were recently constructed and have shown significant improvement in local control and treatment-related toxicities with 3D-IGABT. Finally, we discuss other advances in the field, notably the use of stereotactic body radiotherapy (SBRT) as a substitute to brachytherapy, and the addition of immunotherapy to chemoradiation. Conclusions: The use of IG-IMRT and 3D-IGABT have considerably improved treatment outcomes and toxicity profiles for patients with LACC, and are now considered the gold standard in many countries. The use of SBRT boost as a replacement for brachytherapy has been associated with increased toxicity and decreased efficacy and should be used with caution in the context of clinical trials. New experimental approaches include the addition of immunotherapy to chemoradiation regimens.

Advances in Radiation Oncology: Current Status and Future Directions in India

Cancer and Radiation Therapy: Current Advances and Future Directions

Recent advances in radiation oncology

Radiotherapeutic advances in the management of glioblastoma

The modern landscape of radiotherapy in thyroid malignancies

Bringing proton therapy to India: Gupta et al.'s recent article on revolutionizing cancer treatment in India

Advances in Radiation Oncology for the Treatment of Cervical Cancer

Global Workforce and Access: Demand, Education, Quality

A Comprehensive Review on Novel Pathways in Cancer Treatment: Clinical Applications and Future Prospects

Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities

The current state and future perspectives of radiotherapy for cervical cancer

New developments in arc radiation therapy: A review

Advancements in radiobiology techniques and applications for personalized radiation therapy in nuclear medicine

Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy

A comprehensive overview of radiation therapy impacts of various cancer treatments and pivotal role in the immune system

Review of Image guided radiotherapy

Practice changing data and emerging concepts from recent radiation therapy randomised clinical trials

Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions

Medical radiation countermeasures for nuclear and radiological emergencies: Current status and future perspectives

Stereotactic radiosurgery in India: A nationwide survey of technology and quality assurance practices

Current Status of Radiation Therapy for Prostate Cancer